1. Home
  2. JXG vs NVNO Comparison

JXG vs NVNO Comparison

Compare JXG & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

HOLD

Current Price

$3.90

Market Cap

7.5M

Sector

N/A

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$9.88

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JXG
NVNO
Founded
N/A
1987
Country
China
United States
Employees
N/A
33
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
7.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JXG
NVNO
Price
$3.90
$9.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.9K
6.0K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
$0.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.30
52 Week High
$10.29
$13.44

Technical Indicators

Market Signals
Indicator
JXG
NVNO
Relative Strength Index (RSI) 50.58 38.04
Support Level $3.74 $9.81
Resistance Level $3.94 $12.69
Average True Range (ATR) 0.10 0.69
MACD -0.01 -0.24
Stochastic Oscillator 41.18 14.27

Price Performance

Historical Comparison
JXG
NVNO

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: